Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of KRAS Vaccine in the Treatment of KRAS-mutant Malignancies

NCT07004244 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT07004244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07004244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of KRAS Vaccine in the Treatment of KRAS-mutant Malignancies
Lead sponsor
Sichuan University
Phase
Phase 1
Overall status
Recruiting
Start date
June 5, 2025
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumors